Tag:
mifamurtide
Latest Headlines
Latest Headlines
IDM shares plunge on FDA's rejection
The FDA has turned thumbs down on IDM Pharma's mifamurtide, which was developed to treat a rare form of bone cancer. The agency is looking for more clinical data, says IDM, adding that company
